Verified email at
Cited by
Cited by
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ...
PloS one 4 (12), e8199, 2009
Differential colorectal carcinogenesis: Molecular basis and clinical relevance
A Morán, P Ortega, C de Juan, T Fernández-Marcelo, C Frías, ...
World journal of gastrointestinal oncology 2 (3), 151, 2010
Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications
C Garcia‐Aranda, C de Juan, A Diaz‐Lopez, A Sanchez‐Pernaute, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer
C Frías, C García-Aranda, C De Juan, A Morán, P Ortega, A Gómez, ...
Lung cancer 60 (3), 416-425, 2008
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer
D Serrano, AM Bleau, I Fernandez-Garcia, T Fernandez-Marcelo, ...
Molecular cancer 10, 1-15, 2011
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer
P Iniesta, A Morán, C De Juan, A Gómez, F Hernando, C García-Aranda, ...
Oncology reports 17 (1), 217-223, 2007
Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer
A Moran, P Iniesta, C Garcia-Aranda, C De Juan, A Díaz-López, ...
Oncology reports 13 (1), 115-120, 2005
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
FJ Vega, P Iniesta, T Caldes, A Sanchez, JA Lopez, C De Juan, ...
British journal of cancer 76 (1), 44-51, 1997
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway
P Ortega, A Moran, T Fernandez-Marcelo, C De Juan, C Frias, ...
International journal of oncology 36 (5), 1209-1215, 2010
Clinical relevance of telomere status and telomerase activity in colorectal cancer
T Fernández-Marcelo, A Sánchez-Pernaute, I Pascua, C De Juan, J Head, ...
PloS one 11 (2), e0149626, 2016
Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
M de Mingo, A Morán, A Sanchez-Pernaute, P Iniesta, L Diez-Valladares, ...
Hepato-gastroenterology 54 (73), 315-319, 2007
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status
T Fernández-Marcelo, A Gómez, I Pascua, C de Juan, J Head, ...
Journal of Experimental & Clinical Cancer Research 34, 1-7, 2015
Cooperative Role of Telomerase Activity and p16 Expression in the Prognosis of Non–Small-Cell Lung Cancer
R González-Quevedo, P Iniesta, A Morán, C de Juan, ...
Journal of clinical oncology 20 (1), 254-262, 2002
Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma
FJ Rodríguez-Jiménez, T Caldés, P Iniesta, JA Vidart, JL Garcia-Asenjo, ...
Oncology reports 17 (6), 1301-1307, 2007
Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer
MJ Massa, P Iniesta, R Gonzalez-Quevedo, C De Juan, T Caldes, ...
European Journal of Cancer 35 (12), 1676-1682, 1999
Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer
T Caldes, P Iniesta, FJ Vega, C de Juan, JA Lopez, E Diaz-Rubio, ...
Oncology 55 (3), 249-257, 1998
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability
P Ortega, A Morán, C de Juan, C Frías, S Hernández, JA López-Asenjo, ...
Clinical cancer research 14 (4), 995-1001, 2008
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors
A Morán, P Iniesta, C de Juan, R González-Quevedo, ...
Cancer research 62 (13), 3855-3860, 2002
Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications
R González-Quevedo, C García-Aranda, A Morán, C De Juan, ...
International journal of oncology 24 (2), 349-355, 2004
p53 exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer
P Iniesta, FJ Vega, T Caldés, MJ Massa, C de Juan, FJ Cerdán, ...
Cancer letters 130 (1-2), 153-160, 1998
The system can't perform the operation now. Try again later.
Articles 1–20